Hi Oliver, 
Thank you for bringing this issue to my (our) attention. 
I have already sent a support mail to David because I believe MolProbity is 
very useful for both research and teaching. 
Best regards, 
Nadir 

Pr. Nadir T. Mrabet 
Structural & Molecular Biochemistry 
N-gere - INSERM U-964 
University of Lorraine, Nancy 
School of Science and Technology 
and School of Medicine 
9, Avenue de la Foret de Haye 
54500 Vandoeuvre-les-Nancy, France 
Tel. (direct) : +33 (0)3.83.68.32.73 
Tel. (secretary) : +33 (0)3.83.68.32.92 
Cell. : +33 (0)6 11 35 69 09 
Fax. : +33 (0)3.83.68.32.79 
Email : Nadir.Mrabet <at> univ-lorraine.fr 
----- Mail original -----

> If you find MolProbity a useful tool then please look at the statement
> at the top of

> http://molprobity.biochem.duke.edu/

> The statement reads:

> "URGENT: For the survival of MolProbity, we need your supporting
> comments or letters.
> The MolProbity renewal NIH grant scored well but not well enough,
> and reviewers specifically
> asked for more user feedback. Please send us your stories about
> how you use MolProbity,
> why you value it, and how it has helped your research. We are
> resubmitting the grant -- to
> maintain the resource, update features, and develop new ways to
> help people do much
> better at low resolution.

> Send to [email protected], before February 20 -- either a
> formal letter of support,
> or just useful, quotable comments in email. "

> I find MolProbity very useful and am just drafting such an email.

> Hope it is OK to send this to the ccp4bb. Many people use MolProbity
> from their own sites, or
> using 3rd party software tools (such as buster-report or the wwPDB
> validation server) so they
> would not have seen the message.

> Oliver

> ------------------
> Dr Oliver Smart
> Director SmartSci Limited
> http://www.smartsci.uk/
> & Consultant Global Phasing Ltd
> http://www.globalphasing.com/

Reply via email to